PSI Events

  • 04 May 2017

    Personalised Medicine: Statistics for Companion Diagnostics

    This webinar will introduce and examine some of the considerations required for statisticians working in the field of companion diagnostics and will include information from an FDA (CDRH) speaker and perspectives/ case-studies from representatives from both a pharmaceutical company and a diagnostic company.
  • 11 May 2017

    Expert Working Group on Confidentiality of Interim Results

    The PSI/EFSPI expert working group on Confidentiality of Interim Results are planning to meet face to face on 11 May.
  • 13 Jun 2017

    Patient Engagement in Clinical Trials Webinar

    Following on from the successful and thought-provoking presentation at last year’s PSI conference by Paul Wicks from PatientsLikeMe, this webinar will continue to explore the ways in which patients are influencing the design of new clinical trials.
  • 15 Jun 2017

    BBS / PSI One-day Event on Cancer Immunotherapy

    This joint Basel Biometric Society / PSI one day meeting will present an overview of the science and potential statistical challenges across a range of topics covering early and late phases of development, regulatory and health technology assessments.
  • 19 Jun 2017

    PSI One Day Meeting: Career Young Statisticians

    The aim of this meeting is to provide a relaxed environment for career young statisticians where they can present and discuss various statistical topics and interact/network with other statisticians in similar positions to themselves.
  • 28 Jun 2017

    Estimating Sample Sizes in Clinical Trials

    The three most important aspects of a clinical trial are: design, design and design. A sample size estimate is just one aspect of a clinical study design. The course describes calculations for sample size estimation in the design of clinical trials. It will be highlighted how the objectives of a clinical trial will impact on sample size calculations. The course is a practical course and all methods will be illustrated with examples and case studies.
  • 01 Oct 2017

    Introduction To Industry Training Course 2017

    AIM: To describe the drug development process from research right through to research, toxicology, data management & role of the CRO, clinical trials, product development & manufacture and marketing.

Latest News

Show all news
Merck Logo2

Associate Director, Biostatistician



Medical Statistician / Senior Medical Statistician



Associate Director, Statistics Team leader - Early Clinical Development



Early Clinical Development – various levels



Biostatistics Head of Department



Principal Statistician – Centralised Statistical Monitoring



Clinical Trial Design Methodology Expert - Statistical Innovation Team